news Zealand starts clinical development of a multiple-dose version of ZP4207 20 May 2015 | By Victoria White Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
news Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines 4 August 2014 | By Boehringer Ingelheim & Zealand Pharma Zealand Pharma and Boehringer Ingelheim jointly announced a new global exclusive licence, research and development collaboration...